José Alejandro Guzmán-Solórzano
YOU?
Author Swipe
View article: Interactions between the principal risk factors for reduction of the eGFR in unvaccinated COVID‑19 survivors: Normal pre-COVID‑19 eGFR, not having diabetes and being hospitalized
Interactions between the principal risk factors for reduction of the eGFR in unvaccinated COVID‑19 survivors: Normal pre-COVID‑19 eGFR, not having diabetes and being hospitalized Open
There are contradictory results regarding changes in estimated glomerular filtration rate (eGFR) in coronavirus disease 2019 (COVID-19) survivors. An analysis of eGFR changes and clinical characteristics associated with those changes was c…
View article: [Obesity, CKD and gender on the 30-day in-hospital mortality risk in adults with COVID-19].
[Obesity, CKD and gender on the 30-day in-hospital mortality risk in adults with COVID-19]. Open
A high mortality was observed among the hospitalized patients analyzed and statistically significant factors associated with their risk were identified (gender, obesity, and kidney disease).
View article: Empirical Antibiotic Prescribing in Adult COVID-19 Inpatients over Two Years in Mexico
Empirical Antibiotic Prescribing in Adult COVID-19 Inpatients over Two Years in Mexico Open
Background and Objectives: Empirical antibiotic prescribing in patients with coronavirus disease 2019 (COVID-19) has been common even though bacterial coinfections are infrequent. The overuse of antibacterial agents may accelerate the anti…
View article: COVID-19 vaccines provide better protection against related pneumonia than previous symptomatic infection
COVID-19 vaccines provide better protection against related pneumonia than previous symptomatic infection Open
Our results suggest, and if later replicated, that COVID-19 vaccines provide better protection against pneumonia than previous symptomatic infections. Therefore, offering vaccination to all eligible subjects despite past COVID-19 infection…
View article: Efficacy of the use of mefenamic acid combined with standard medical care vs. standard medical care alone for the treatment of COVID‑19: A randomized double‑blind placebo‑controlled trial
Efficacy of the use of mefenamic acid combined with standard medical care vs. standard medical care alone for the treatment of COVID‑19: A randomized double‑blind placebo‑controlled trial Open
Mefenamic acid is a non‑steroidal anti‑inflammatory drug exhibiting a wide range of anti‑inflammatory, antipyretic, analgesic and probable antiviral activities. The present study evaluated the efficacy of treatment with mefenamic acid comb…